This compound is primarily used in the synthesis of pharmaceutical intermediates, particularly in the development of active pharmaceutical ingredients (APIs) targeting neurological and psychiatric disorders. Its structure, featuring a fluorophenyl group and a Boc-protected amine, makes it valuable for constructing peptide-like molecules and modulators of biological pathways. It is often employed in medicinal chemistry research to develop compounds with potential therapeutic effects, such as enzyme inhibitors or receptor ligands. The fluorine atom enhances the molecule's binding affinity and metabolic stability, making it a key component in drug discovery programs. Additionally, it is utilized in the preparation of chiral building blocks for asymmetric synthesis, contributing to the production of enantiomerically pure drugs.